Queen’s University Health Sciences and Affiliated Teaching Hospitals Research Ethics Board (HSREB) is the authority to review proposed research involving human participants that are being conducted under the auspices of Queen's University. HSREB primarily has ethics authority over health science research, including all research being conducted at the affiliated teaching hospitals Kingston Health Sciences Centre (KGH and HDH Sites), Providence Care Centre (PCC) and Ongwanada.
When submitting to HSREB, researchers are expected to provide clear and comprehensive documentation, demonstrating a thorough understanding of ethical considerations. The submission process, marked by transparency and collaboration, reflects Queen’s commitment to responsible and ethical research practices.
Learn more about HSREB Terms of Reference.
Vision
The vision of the Queen’s University Health Sciences and Affiliated Teaching Hospitals Research Ethics Board (HSREB) is to provide education, guidance, and oversight for research involving human participants.
Mission
The mission of Queen’s University Health Sciences and Affiliated Teaching Hospitals Research Ethics Board (HSREB) is to ensure that research involving human participants follows equity-oriented principles. The HSREB shall promote education and ongoing training for all researchers and its REB members, facilitate the review
Dear students, faculty, and staff,
As Chair of Queen’s University Health Sciences and Affiliated Teaching Hospitals Research Ethics Board (HSREB), I warmly welcome you to research ethics. Research of all types is a rewarding experience for our national and international communities, and many people benefit daily from the innovative developments and extended understanding that research creates.
I would like to confirm the HSREB’s mission to ensure that our research involving human participants follows equity-oriented principles. Further, the Queen’s HSREB shall promote education and ongoing training for all researchers and its REB members, facilitating the review process through guidance and support to the researchers in the submission and review process, and developing and implementing policies and procedures that ensure research compliance with evolving provincial, national, and international guidelines (i.e., the Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans). The Queen’s HSREB shall function as an autonomous entity and recognize that all members of the University community share a joint commitment to maintaining research integrity and the highest concern for human dignity, welfare, and justice.
Queen’s University is committed to advancing excellence in research and scholarship. At the core of research excellence is adherence to the highest standards of research integrity. Research integrity means that researchers will conduct and communicate their research honestly and carefully. Researchers must also conduct themselves as professionals, ensuring that standards and policies that guide ethical research are understood and adhered to. Research integrity is expected throughout the research process, from choosing a topic to an endpoint, such as communicating what the research found and the implications of such findings. At Queen’s, research integrity requires adherence to the highest ethical and professional standards and goes beyond merely avoiding misconduct.
At Queen’s, as in other Canadian Universities, the Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans (TCPS 2) is the prevailing Canadian standard for ethical research; Health Canada and PHAC have adopted TCPS to guide the ethical aspects of the design, review and conduct of research involving humans.
The guidelines in the TCPS2 are based on the following core principles: a) ;Respect for Persons, b) Concern for Welfare, and c) Justice. These principles are complementary and inter-reliant. Of course, how these principles apply, and the weight given to each will depend on the nature and situation of the research being undertaken. The TCPS2 is a joint policy of Canada’s three federal research agencies – the Canadian Institutes of Health Research (CIHR), the Natural Sciences and Engineering Research Council of Canada (NSERC), and the Social Sciences and Humanities Research Council of Canada (SSHRC). TCPS 2 is the foundation for the REB’s operational and guidance documents, which include the Operational Policy Framework, evaluation criteria and requirements for informed consent. Where applicable, the REB also considers relevant federal laws and regulations, such as the Privacy Act and clinical trial regulations. Finally, I want to encourage you to engage in research and the many rewarding and exciting outcomes the process involves. Please visit the HSREB website for all relevant information concerning our ethics board.
Sincerely,
Dean A. Tripp, PhD
Professor & Chair of Queen’s University Health Sciences and Affiliated Teaching Hospitals Research Ethics Board (HSREB)
The Kingston Health Sciences Centre Operating Agreement assures the preservation of the continued Catholic mission and approach at its Hotel Dieu Hospital (HDH) Site. Providence Care Hospital (PCH) is also a Catholic-sponsored healthcare organization. As such, individuals undertaking research at HDH and/or PCH will uphold the Catholic Values outlined by The Catholic Health Alliance of Canada in accordance with the Health Ethics Guide.
Current Members as of September 1, 2025
- Dr. D. A. Tripp, Chair – Professor, Departments of Psychology, Anesthesia and Urology, Queen’s University
- Dr. A. Ellis, Vice-Chair – Professor, Department of Medicine, Queen’s University
- Dr. A. K. Woodhouse, Vice-Chair – Professor Emerita, Department of Chemical Engineering, Queen’s University
- Dr. R. Brison, Assistant Vice-Chair – Professor, Department of Emergency Medicine, Queen’s University
- Dr. H. Abdollah – Professor, Department of Medicine, Queen’s University
- Dr. A. Agrawal – Chair, Division of Gynecologic Oncology, Assistant Professor, Department of Obstetrics and Gynecology
- Dr. N. Alavi – Associate Professor, Department of Psychiatry, Queen’s University
- Dr. M. Beyak – Associate Professor, Department of Medicine, Division of Gastroenterology
- Mr. D. Buskermolen – Community Member
- Dr. J. Butler – Assistant Professor, Department of Biomedical and Molecular Sciences
- Dr. M. Derynck – Assistant Professor, Department of Pediatrics, Queen’s University
- Dr. I. Galvin – Assistant Professor, Department of Anesthesiology and Perioperative Medicine, Queen’s University
- Dr. P. Glynn – Community Member
- Ms. S. Morton – University Secretariat and Legal Counsel
- Ms. N. Jawa – MD/PhD Candidate, Centre for Neuroscience Studies, Queen’s University
- Dr. J. Mathews – Assistant Professor, Department of Medicine, Queen’s University
- Dr. L. Ossher – Scientific and Community Member
- Ms. J. Raymond – Law and Community Member
- Mr. A. Rogers – Privacy Officer and Freedom of Information Coordinator, Kingston Health Sciences Centre
- Dr. Z. Samaan – Professor and Head, Department of Psychiatry, Queen’s University
- Dr. A. Singh – Professor, Department of Psychiatry, Queen's University
- Dr. C. Soares – Professor, Department of Psychiatry, Queen's University
- Dr. A. Thai – Epidemiologist, Public Health Agency of Canada (Community Member)
- Dr. M. Tohidi – Assistant Professor, Department of Surgery, Queen's University
- Ms. M. Tryon – Clinical Pharmacist, Pharmacy Services, Kingston Health Sciences Centre
HSREB Meeting Schedules
Ethics applications must be submitted at least three weeks before the meeting to allow time for review. Incomplete applications will be returned for updates and will not move forward to the full board until revised. Submitting early helps avoid delays in the HSREB review process.
Low-risk studies are reviewed outside of full board meetings and are exempt from these deadlines.
| Date for Submission | Meeting Date |
|---|---|
| December 12, 2025 | January 12, 2026 |
| January 19, 2026 | February 9, 2026 |
| February 24, 2026 | March 16, 2026 |
| March 23, 2026 | April 13, 2026 |
| April 20, 2026 | May 11, 2026 |
| May 18, 2026 | June 8, 2026 |
| June 22, 2026 | July 13, 2026 |
| July 20, 2026 | August 10, 2026 |
| August 24, 2026 | September 14, 2026 |
| September 28, 2026 | October 19, 2026 |
| October 19, 2026 | November 9, 2026 |
| November 23, 2026 | December 14, 2026 |
| Date for Submission | Meeting Date |
|---|---|
| December 23, 2024 | January 13, 2025 |
| January 20, 2025 | February 10, 2025 |
| February 24, 2025 | March 17, 2025 |
| March 24, 2025 | April 14, 2025 |
| April 21, 2025 | May 12, 2025 |
| May 19, 2025 | June 9, 2025 |
| June 23, 2025 | July 14, 2025 |
| July 21, 2025 | August 11, 2025 |
| August 25, 2025 | September 15, 2025 |
| September 29, 2025 | October 20, 2025 |
| October 20, 2025 | November 10, 2025 |
| November 17, 2025 | December 8, 2025 |
| Date for Submission | Meeting Date |
|---|---|
| December 22, 2023 | January 15, 2024 |
| January 22, 2024 | February 12, 2024 |
| February 26, 2024 | March 18, 2024 |
| March 25, 2024 | April 15, 2024 |
| April 22, 2024 | May 13, 2024 |
| May 20, 2024 | June 10, 2024 |
| June 24, 2024 | July 15, 2024 |
| August 19, 2024 | September 9, 2024 |
| September 23, 2024 | October 21, 2024 |
| October 28, 2024 | November 18, 2024 |
| November 18, 2024 | December 9, 2024 |
Paying the HSREB Fee
The HREB Fee is a one-time, non-refundable fee of $4,000 CAD is required for all ethics reviews for industry-funded and/or industry-supported studies. The fee is also required for all in-kind support (e.g., drug, devices in kind), and external organizations seeking an independent REB review*.
The REB review fee may be waived for:
- unfunded studies
- internally funded studies (i.e. studies funded through internal awards/grants from Queen’s University or affiliated hospitals, Kingston Health Science Centre, and Providence Care Centre)
- grant-funded studies from a public, charitable,or not‐for‐profit organization (e.g., Tri-agency, Canadian Cancer Society, Heart and Stroke Foundation)
- studies initiated, authored, and/or conducted by Queen’s University-affiliated researchers whereby the researcher owns all intellectual property and can alter the research without influence from the funder/not-for-profit organization
* A Board of Record agreement must be developed for all external REB reviews.
Need assistance?
Contact our team
The Queen's Research Ethics team is here to provide guidance and support so you can move your research forward with confidence.
Ethics toolbox
This archive of resources provides guidelines, checklists, and templates for ethics applications and event reporting.
Drop-in sessions
Join the Research Ethics team at our weekly virtual drop-in sessions and get your questions answered.
Raising Concerns About Research Ethics
If you have concerns regarding the ethical conduct of a research study conducted under the authority of Queen’s University, don't hesitate to get in touch with the Research Ethics Office:
Toll-Free Telephone in North America: 1-844-535-2988
Email: researchethics@queensu.ca
Queen's Federalwide Assurance Number: FWA00004184
HSREB IRB Number: IRB00001173